Skip to main content

Peer Review reports

From: Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38

Original Submission
20 Sep 2016 Submitted Original manuscript
17 Mar 2017 Reviewed Reviewer Report - Joan Lewis-Wambi
8 May 2017 Reviewed Reviewer Report - Hamidreza Montazeri Aliabadi
9 May 2017 Reviewed Reviewer Report - Andreja Ambriovic-Ristov
29 Jun 2017 Author responded Author comments - Katharina Gohr
Resubmission - Version 2
29 Jun 2017 Submitted Manuscript version 2
10 Aug 2017 Reviewed Reviewer Report - Andreja Ambriovic-Ristov
26 Sep 2017 Author responded Author comments - Katharina Gohr
Resubmission - Version 3
26 Sep 2017 Submitted Manuscript version 3
Publishing
19 Oct 2017 Editorially accepted
3 Nov 2017 Article published 10.1186/s12885-017-3695-5

You can find further information about peer review here.

Back to article page